Literature DB >> 9532530

Ocular neuromyotonia: three case reports with eye movement recordings.

R D Yee1, V A Purvin.   

Abstract

The objective of this article was to evaluate the etiologies, findings, and treatment of ocular neuromyotonia (ONM) in three case reports. The etiologies of ONM were determined by the histories, neuroradiologic tests, or biopsies. Clinical observations, videotaping, and electronic eye movement recordings documented the eye movement abnormalities. Intermittent diplopia developed several years after myelography with thorium dioxide (Thorotrast), radiation treatment for a pituitary tumor, and radiotherapy for medulloblastoma of the posterior fossa. All of the patients had intermittent, variable tropias that occurred spontaneously or were induced by eccentric gaze. One patient had a partial third nerve palsy, and another had a unilateral internuclear ophthalmoplegia (INO). ONM involved the paretic third nerve, extraocular muscles, and ipsilateral lateral rectus muscle in one patient, the paretic medial rectus muscle (INO) in one patient, a lateral rectus muscle (INO) in one patient, and a lateral rectus muscle in the last patient. Eye movement recordings were consistent with spasms of the involved muscles. Carbamazepine (Tegretol) abolished the ONM in two patients. The other patient had been taking carbamazepine for seizures and developed ONM when the dose was decreased. Increasing the dose abolished the ONM. ONM is an unusual cause of intermittent diplopia and strabismus, but its distinctive history and signs identify it easily. Damage to the peripheral cranial nerves might produce segmental demyelination, axonal hyperexcitability, and a self-perpetuating, reverberating circuit that causes spasms of the extraocular muscles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9532530

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  5 in total

1.  Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression.

Authors:  Maurizio Versino; Silvia Colnaghi; Alessandra Todeschini; Elisa Candeloro; Sabrina Ravaglia; Arrigo Moglia; Vittorio Cosi
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

Review 2.  Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt; Katharina Feil
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

3.  Strabismus Surgery in Patients With Ocular Neuromyotonia: Potential Unmasking of the Condition and Effective Management Tool.

Authors:  J Anna Kim; Federico G Velez; Stacy L Pineles
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

4.  [Ocular neuromyotonia after radiation therapy].

Authors:  M van Waveren; V Herzau; D Besch
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

5.  Bilateral oculomotor ocular neuromyotonia: a case report.

Authors:  Tanyatuth Padungkiatsagul; Panitha Jindahra; Anuchit Poonyathalang; Narong Samipak; Kavin Vanikieti
Journal:  BMC Neurol       Date:  2018-09-03       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.